Halozyme Therapeutics Inc.

NASDAQ:HALO  
38.82
+0.08 (+0.21%)
Debt Financing / Related

Halozyme Therapeutics Entered Into Amendment No. 1 To Credit Agreement

Published: 08/19/2022 21:31 GMT
Halozyme Therapeutics Inc. (HALO) - Halozyme Therapeutics Inc - Entered Into Amendment No. 1 to Credit Agreement.
Halozyme Therapeutics Inc - Amendment, Among Other Things, Increases Size of Revolving Credit Facility From $350 Million to $575 Million.